Zhixia Zhou

Assistant Professor

zhou_zhixia@qdu.edu.cn

Phone: 86-18563917312

Office: Room 816, No. 38 Dengzhou Road,

University of Qingdao, China

/info/2015/1173.htm

 
Education

Ph.D, Institute of Immunopharmaceutical Sciences, School of Pharmaceutical Sciences, Shandong University, 2012.

 
Research Interests

Dr. Zhou’s research interests cover basic innate immunity and immunoregulation, tumor immunology and therapeutics.

 
Selected Publications

1. Zhou Zhixia^#*; Zhang Yinfeng; Gao Jinning; Hao Xiaodan; Shan Chan; Li Jing ; Liu Cuiyun; Wang Yin; Li Peifeng*. Circular RNAs act as regulators of autophagy in cancer. Mol Ther Oncolytics. 2021, 21:242-254.

2. Zhou Zhixia*; Gong Qi; Wang Yin; Li Mengkun; Wang Lu; Ding Hongfei; Li Peifeng*. The biological function and clinical significance of SF3B1 mutations in cancer. Biomarker Research. 2020, 8: 38.

3. Zhou Zhixia^#; Lin Zhijuan^#; He Yuqi; Pang Xin; Wang Yin; Ponnusamy Murugavel; Ao Xiang; Shan Peipei; Li Peifeng*; Wang Jianxun*. The long noncoding RNA D63785 regulates chemotherapy sensitivity in human gastric cancer by targeting miR-422a. Molecular Therapy-Nucleic Acids, 2018,12: 405-419.

4. Lin Zhijuan^#; Zhou Zhixia^#; Guo Hang; He Yuqi; Pang Xin; Zhang Xumei; Liu Ying; Ao Xiang; Li Peifeng*; Wang Jianxun*. Long noncoding RNA gastric cancer-related lncRNA1 mediates gastric malignancy through miRNA-885-3p and cyclin-dependent kinase 4. Cell Death & Disease, 2018, 9(6): 607.

5. Zhou Zhixia^#; Yu Xin; Zhang Jian; Tian Zhigang*; Zhang Cai*.TLR7/8 agonists promote NK-DC cross-talk to enhance NK cell anti-tumor effects in hepatocellular carcinoma. Cancer Letters, 2015, 369(2): 298-306.

6. Zhou Zhixia^#; Zhang Cai*; Xia Chengfeng; Chen Wenlan; Zhu Huawei; Shang Pingping; Ma Fang; Wang Peng George; Zhang Jian; Xu Wenfang; Tian Zhigang*. Enhanced antitumor effects by chemical modified IGb3 analogues, Molecular Cancer Therapeutics, 2011, 10(8):1375-1384.